{
  "meta": {
    "title": "Cholinergic_Drugs_Anticholinergic_Drugs",
    "url": "https://brainandscalpel.vercel.app/cholinergic-drugs-anticholinergic-drugs-4ec22062.html",
    "scrapedAt": "2025-11-30T11:19:46.781Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">cAMP</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">DAG</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Depolarising influx of sodium ions via a channel</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">IP3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the primary second messenger in the contraction of the ciliary muscles when focusing on near objects?</span></p>",
      "unique_key": "DT1166317",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166317,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>IP3 </strong>is the<strong> primary second messenger</strong> in the contraction of the ciliary muscles when focusing on near objects. </p>\n<p><strong>Cholinomimetics</strong> primarily cause smooth muscle contraction through their action on M3 Gq-coupled receptors, leading to the release of intracellular calcium. This release is triggered by an increase in IP3 acting on <strong>IP3 receptors </strong>in the <strong>endoplasmic reticulum.</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906a1e80cca-ad1d-4485-98a5-dfc101800f8f.PNG\">\n<h3>Hormone Classification</h3>\n<h3>Types of Hormones</h3>\n<ul>\n<li>Insulin / Hypothalamic / Pituitary hormones</li>\n<li>These are polypeptide hormones that act via<strong> cell surface receptors</strong></li>\n</ul>\n<h3>Types of Cell Surface Receptors</h3>\n<h3>a. Tyrosine Kinase Receptors (TK): Activate Phosphatidylinositol cascade (PIG)</h3>\n<h4>b. GPCRs (G-protein Coupled Receptors): Non-PIG linked</h4>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906b05a4f4e-e821-400e-9287-e909d59c6416.PNG\">\n<h3>Steroid Hormone Receptors</h3>\n<p>Lipid-soluble &rarr; Intracellular receptors</p>\n<ul>\n<li>Cortisol &rarr; Cytoplasmic receptor</li>\n<li>Others &rarr; Nuclear receptor</li>\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Cause ganglion cell depolarisation</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Cause vasodilation</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase bronchial smooth muscle tone</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase heart rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Parasympathetic nerve stimulation and a slow infusion of bethanechol will each cause this.</span></p>",
      "unique_key": "DT1166321",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166321,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Parasympathetic nerve stimulation and a slow infusion of bethanechol will each cause an increase in <strong>bronchial smooth muscle tone.</strong></p>\n<ul>\n<li><strong>Bethanechol:</strong> A muscarinic receptor agonist (specifically M3), mimics parasympathetic stimulation. </li>\n<li><strong> Parasympathetic stimulation + Bethanechol</strong>: Increases bronchial smooth muscle tone (via M3 receptor activation), which causes bronchoconstriction.</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Cause ganglion cell depolarisation (Option A):</strong> Ganglion cells and the end plate contain nicotinic receptors, which are not affected by bethanechol, a direct-acting muscarinic agonist.</p>\n<p><strong>Cause vasodilation (Option B):</strong> Parasympathetic nerve stimulation does not cause vasodilation (most vessels do not receive parasympathetic innervation, even though some muscarinic receptors might be present there), so the choice is incorrect.</p>\n<p><strong>Increase heart rate (Option D):</strong> It does not increase heart rate; it typically decreases it via M2 receptors.</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchodilation (treatment of asthma)</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Miosis (treatment of narrow-angle glaucoma)</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased gastrointestinal motility (treatment of diarrhoea)</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased neuromuscular transmission and relaxation of skeletal muscle (during surgical anaesthesia)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Actions and clinical uses of muscarinic cholinoceptor agonists include which one of the following?</span></p>",
      "unique_key": "DT1166328",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166328,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Muscarinic cholinergic receptor agonists </strong>aid in miosis and the treatment of narrow-angle glaucoma.</p>\n<ul>\n<li>Muscarinic agonists cause accommodation and cyclospasm, the opposite of paralysis of accommodation <strong>(cycloplegia)</strong>.</li>\n<li>Although not drugs of choice, in acute<strong> angle-closure glaucoma,</strong> this may result in a desirable increased outflow of the aqueous and a <strong>decrease in the intraocular pressure.</strong></li>\n<li>Muscarinic cholinergic receptor agonists may cause bronchospasm but do not affect neuromuscular transmission.</li>\n<li>Succinylcholine blocks the action of acetylcholine at the nicotinic receptor.</li>\n</ul>\n<h4>Muscarinic cholinoceptor agonists (e.g. pilocarpine, bethanechol) activate parasympathetic muscarinic receptors, leading to:</h4>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906d390eff5-5240-4895-81e9-8e3de07464a7.PNG\">\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Bronchodilation (treatment of asthma) (Option A): </strong>Muscarinic agonists cause bronchoconstriction, not bronchodilation.</p>\n<p><strong>Decreased gastrointestinal motility (treatment of diarrhoea) (Option C): </strong>They increase GI motility and would worsen diarrhoea.</p>\n<p><strong>Decreased neuromuscular transmission and relaxation of skeletal muscle (Option D): </strong>Muscarinic agonists do not act on nicotinic receptors at the neuromuscular junction.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbachol</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Benztropine</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Pralidoxime</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old man with Alzheimer's disease is brought in with abdominal cramps, diarrhoea, diaphoresis, and muscular weakness and spasms in his extremities. He has ingested an excessive amount of medications in a suicide attempt. His temperature is 38.4&deg;C (101.1&deg;F), pulse is 51/min, respirations are 12/min and laboured, and blood pressure is 88/56 mm Hg. Treatment is initiated. Shortly after, most of his symptoms had resolved, but he continues to have muscular spasms. Administration of which of the following is the most appropriate next step in the treatment of this patient?</span></p>",
      "unique_key": "DT1166344",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient presents with symptoms of <strong>muscarinic acetylcholine excess</strong> (e.g., diarrhoea, diaphoresis, bradycardia, bronchospasm, salivation, lacrimation, miosis) and <strong>nicotinic acetylcholine excess</strong> (e.g., muscle weakness).</p>\n<ul>\n<li>Atropine can only reverse the muscarinic effects.</li>\n<li>When taken in excess, medications for Alzheimer's disease, such as donepezil, can result in symptoms similar to those of <strong>organophosphate poisoning. </strong></li>\n<li>In such cases, <strong>pralidoxime</strong> is given to restore the activity of acetylcholinesterase, which then catalyses the breakdown of excessive acetylcholine to reverse symptoms.</li>\n<li><strong>Atropine</strong> does not act on nicotinic cholinergic receptors and thus cannot treat symptoms of neuromuscular dysfunction, for which <strong>pralidoxime </strong>is still necessary.</li>\n</ul>\n<p><strong>Pralidoxime</strong> has poor blood-brain barrier penetration and can lead to a transient worsening of acetylcholinesterase inhibition following administration, which is why atropine is typically administered first to treat CNS symptoms and prevent further acetylcholinesterase inhibition.</p>\n<p><strong>Management of </strong><strong>a patient with suspected OP poisoning:</strong></p>\n<ul>\n<li>Patient decontamination (e.g., remove clothes, wash skin)</li>\n<li>Secure airways, oxygen therapy, and ECG</li>\n<li>Measurement of erythrocyte cholinesterase activity: &darr; acetylcholinesterase activity</li>\n<li><strong>Atropine</strong></li>\n<li><strong>Oximes:</strong> Pralidoxime (2-PAM), obidoxime\n<ol>\n<li>Regenerate acetylcholinesterase by dephosphorylation</li>\n<li>Function peripherally on both muscarinic and nicotinic receptors</li>\n<li>Should only be administered after atropine due to the risk of transient worsening of acetylcholinesterase inhibition</li>\n</ol>\n</li>\n<li>Benzodiazepines (e.g., diazepam): to control organophosphate-induced seizures.</li>\n</ul>\n<p><strong>Direct-Acting Cholinomimetics</strong> (Muscarinic/Nicotinic Agonists)</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509068b3e12e8-ad8b-4499-b78b-700eae86bb77.PNG\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090638374175-ad7e-4e40-b898-0f56dfa0ff5d.PNG\">",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetylcholine</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Bethanechol</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Neostigmine</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Varenicline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a direct-acting cholinomimetic that is lipid-soluble and is used to facilitate smoking cessation?</span></p>",
      "unique_key": "DT1166363",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166363,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Varenicline</strong> is a lipid-soluble partial agonist at nicotinic receptors and is used to<strong> reduce craving for tobacco in smokers.</strong></p>\n<ul>\n<li>Side effects of this drug include <strong>abnormal dreams</strong> (most common), SJS, and erythema multiforme</li>\n</ul>\n<p><strong>Treatment for smoking cessation:</strong></p>\n<ul>\n<li>Counselling and support</li>\n<li>Varenicline (alpha-4-beta-2 nACHR partial agonist): reduces positive symptoms and prevents withdrawal</li>\n<li>Bupropion: reduces craving and withdrawal symptoms</li>\n<li>Nicotine replacement therapy (inhaler, lozenges, transdermal patch, nasal spray, gum)</li>\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Bethanechol</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Neostigmine</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-year-old child is admitted after consuming multiple tablets. The signs suggest that the drug is a cholinomimetic with little or no vascular effect, little or no CNS effect, and a duration of action of about 2-4 h. Which of the following is the most likely cause of these effects?</span></p>",
      "unique_key": "DT1166368",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166368,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Child Ingests Cholinomimetic drug </strong>and presents with signs including little or no vascular effect, little or no CNS (central nervous system) effect, and a duration of action of about 2-4 hours.</p>\n<ul>\n<li>These signs suggest the child has ingested a cholinomimetic drug primarily acting on muscarinic receptors with limited or no nicotinic receptor activity.</li>\n</ul>\n<p>So, the drug is probably<strong> pilocarpine, </strong>which is a muscarinic agonist primarily affecting the eye and salivary glands.</p>\n<ul>\n<li>Limited vascular and CNS effects.</li>\n<li>Duration of action is within 2-4 hours.</li>\n<li>Used for glaucoma and xerostomia (dry mouth).</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Bethanechol (Option </strong><strong>A):</strong> Muscarinic agonist, primarily affects the GI and urinary tract, leading to increased tone and motility.</p>\n<ul>\n<li>Limited vascular and CNS effects.</li>\n<li>The duration of action is relatively shorter.</li>\n</ul>\n<p><strong>Neostigmine</strong><strong> (Option B):</strong> Reversible acetylcholinesterase inhibitor that increases acetylcholine concentration at both muscarinic and nicotinic receptors.</p>\n<ul>\n<li>Used for myasthenia gravis and reversing non-depolarising neuromuscular blockers.</li>\n<li>Some CNS effects and vascular tone increase.</li>\n</ul>\n<p><strong>Physostigmine</strong><strong> (Option C):</strong> Acetylcholinesterase inhibitor, similar to neostigmine with pronounced muscarinic effects, limited nicotinic effects.</p>\n<ul>\n<li>Used to reverse anticholinergic toxicity.</li>\n<li>Has CNS effects, relatively short duration (30 minutes to 2 hours).</li>\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxazosin</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Bethanechol</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Midodrine</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Tolterodine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old man presents with a complaint of an urge to urinate that occurs suddenly, and he often is unable to make it to the bathroom before leaking urine. He has no incontinence with coughing or laughing. He has multiple sclerosis. Which of the following is the most appropriate pharmacotherapy for this patient's incontinence?</span></p>",
      "unique_key": "DT1166387",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166387,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In a patient with multiple sclerosis, a sudden urge to urinate that is not related to increased intra-abdominal pressure is consistent with <strong>urge incontinence due to detrusor hyperreflexia</strong> (upper motor neuron dysfunction).</p>\n<p><strong>Tolterodine</strong> is an antimuscarinic agent, selective for <strong>M3 receptors</strong> in the bladder that inhibits <strong>detrusor muscle overactivity,</strong> increases bladder capacity. First-line treatment for urge incontinence / overactive bladder and effective in <strong>neurogenic bladder, seen in MS.</strong></p>\n<ul>\n<li>In a healthy individual, bladder wall relaxation due to stimulation of &beta;3 receptors in the detrusor muscle allows storage of urine.</li>\n<li>During the storage phase, contraction of the trigone and sphincter muscles due to stimulation of &alpha;1 receptors at these sites maintains continence.</li>\n<li>Bladder wall contraction due to stimulation of M3 receptors in the detrusor muscle, and reflex inhibition of the trigone and sphincter allows for micturition to occur during the voiding phase.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906ab3b93db-6666-4155-944b-503a25a99922.PNG\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906cc751315-5746-4881-959b-15c0601fd885.PNG\">\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Doxazosin (Option A):</strong> Doxazosin is an &alpha;<sub>1</sub>-adrenergic antagonist that causes relaxation of the bladder neck and prostatic urethra, making it easier to void.</p>\n<ul>\n<li>It is used in the treatment of urinary retention and overflow incontinence caused by bladder outlet obstruction, such as in benign prostatic hyperplasia (BPH) or an overactive sphincter.</li>\n</ul>\n<p><strong>Bethanechol (Option B):</strong> Bethanechol is a parasympathomimetic (muscarinic agonist) that stimulates detrusor muscle contraction.</p>\n<ul>\n<li>It is used to treat urinary retention and overflow incontinence due to an underactive detrusor muscle, which may occur in multiple sclerosis patients with spinal cord lesions below the S1 level.</li>\n</ul>\n<p><strong>Midodrine (Option C):</strong> Midodrine is an &alpha;<sub>1</sub>-adrenergic agonist that increases tone in the urinary sphincter and detrusor muscle, leading to urinary retention.</p>\n<ul>\n<li>It is used in certain cases of stress incontinence caused by sphincter underactivity, such as in MS with lower spinal cord lesions (below S1).</li>\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Edrophonium</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridostigmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman presents with the recent onset of weakness in her hands, diplopia, and difficulty swallowing. She has been treated for myasthenia gravis for several years. Which of the following is the best drug for distinguishing between myasthenic crisis and cholinergic crisis?</span></p>",
      "unique_key": "DT1166389",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166389,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Edrophonium</strong> is the best drug for distinguishing between myasthenic crisis and cholinergic crisis. </p>\n<p>A patient with <strong>myasthenia gravis</strong> presents with worsening muscle weakness and bulbar symptoms (diplopia, dysphagia).</p>\n<p>This could be:</p>\n<ul>\n<li><strong>Myasthenic crisis</strong>: exacerbation of MG due to under-medication, stress, infection, etc.</li>\n<li><strong>Cholinergic crisis</strong>: due to excess acetylcholine (overmedication with AChE inhibitors), leading to desensitised receptors and paradoxical weakness.</li>\n</ul>\n<p><strong>Edrophonium Test (Amelorative/Tensilon Test): </strong>Short-acting acetylcholinesterase inhibitor (~10 min).</p>\n<p><strong>Mechanism:</strong> temporarily increases ACh at the neuromuscular junction.</p>\n<ul>\n<li>If muscle strength improves, &rarr; Myasthenic crisis</li>\n<li>If muscle weakness worsens, &rarr; Cholinergic crisis</li>\n</ul>\n<p>Thus, it helps differentiate between the two crises.</p>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Atropine (Option A): </strong>Muscarinic antagonist used to treat cholinergic toxicity, not a diagnostic tool.</p>\n<p><strong>Physostigmine (Option C): </strong>A tertiary amine AChE inhibitor that crosses the blood-brain barrier. Used primarily for anticholinergic toxicity, not in the diagnosis or management of myasthenia gravis.</p>\n<p><strong>Pyridostigmine (Option D): </strong>A long-acting AChE inhibitor used for maintenance therapy in myasthenia gravis. It does not have the rapid onset or short duration needed for a diagnostic challenge like edrophonium.</p>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">If treated early, its toxicity may be partly reversed by pralidoxime</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">It is less toxic to humans than malathion</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">It is more persistent in the environment than DDT.</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">It is poorly absorbed through the skin and lungs.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old farmer is admitted for Parathion poisoning. Which one of the following is its characteristic feature?</span></p>",
      "unique_key": "DT1166391",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166391,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Parathion</strong> is an organophosphate insecticide. Its characteristic feature is that its toxicity can be partly reversed by <strong>pralidoxime (2-PAM)</strong> if administered early, before <strong>ageing</strong> occurs.</p>\n<p><strong>Mechanism of Organophosphate (OP) Toxicity &amp; Reversal:</strong></p>\n<ul>\n<li>OPs like parathion <strong>inhibit acetylcholinesterase </strong>(AChE) by binding to the serine residue at the esteric site of the enzyme.</li>\n<li>Initially, this binding is reversible.</li>\n<li>Over time, the bond undergoes structural stabilisation, forming a covalent bond at the anionic site, a process known as<strong> \"ageing\".</strong>\n<ol>\n<li>Once ageing occurs, the enzyme is <strong>permanently inactivated.</strong></li>\n<li>The body must then synthesise new AChE, which takes time.</li>\n</ol>\n</li>\n<li><strong>Pralidoxime</strong>, an oxime, has a high affinity for the phosphorus atom in OPs and can reactivate AChE only before ageing.</li>\n<li>This is why <strong>early administration of pralidoxime</strong> is critical.</li>\n</ul>\n<p><strong>Contrast with Carbamates:</strong></p>\n<ul>\n<li><strong>Carbamates </strong>(e.g. physostigmine) bind both esteric and anionic sites.</li>\n<li>This makes oximes ineffective in carbamate poisoning.</li>\n</ul>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 5</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 6, 7</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 6</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 5, 6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old farmer has been accidentally exposed to a high concentration of a highly toxic agricultural organophosphate insecticide. What would be the sign/symptom of the condition ?<br>1. Sweating<br>2. Urination<br>3. Vomiting<br>4. Bradycardia<br>5. Mydriasis<br>6. Bronchorrhea<br>7. Hyperventilation</span></p>",
      "unique_key": "DT1166398",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166398,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Organophosphorus poisoning</strong> causes irreversible acetylcholinesterase inhibition and produces the following effects.</p>\n<p><strong>Muscarinic effects</strong></p>\n<ul>\n<li>Excess of secretions, including salivation, sweating, lacrimation, urination, defecation, and emesis. <strong>(Statements 1, 2, and 3 are true)</strong></li>\n<li>Miosis and blurred vision (Statement 5 is false)</li>\n<li>Bradycardia <strong>(Statement 4 is true)</strong></li>\n<li>Bronchospasm (Statement 7 is false)</li>\n<li>Bronchorrhea <strong>(Statement 6 is true)</strong></li>\n</ul>\n<p><strong>Nicotinic effects:</strong> Blockage at the neuromuscular junction (similar mechanism observed in succinylcholine)</p>\n<p><strong>Systemic effects</strong></p>\n<ul>\n<li>Hypoventilation</li>\n<li>Lethargy</li>\n<li>Seizures, coma</li>\n</ul>\n<p><strong>Antimuscarinic Drugs:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906f32eb57c-c5c4-4976-83d2-6fb77403757e.PNG\">",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased blood pressure</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased bowel sounds</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Miosis</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Tachycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man with a history of major depression is admitted to the emergency department following a suicide attempt with a drug overdose. Which of the following signs or symptoms would be consistent with an overdose of a ganglion-blocking drug?</span></p>",
      "unique_key": "DT1166400",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166400,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Tachycardia </strong>is a symptom that would be consistent with an <strong>overdose of a ganglion-blocking drug.</strong></p>\n<ul>\n<li>Ganglion blockade results in <strong>decreased blood pressure, bowel activity, and sweating.</strong></li>\n<li>Because the parasympathetic system dominates the pupil and the sinoatrial node, ganglion block causes mydriasis and tachycardia.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906cc63c834-3ea7-4a91-8c64-44aaf2f4ab58.PNG\">",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchospasm</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Cycloplegia</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Skeletal muscle spasms</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Bradycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Several children were hospitalised with symptoms thought to be due to ingestion of food containing botulinum toxin. Which one of the following signs or symptoms is consistent with the diagnosis of botulinum poisoning?</span></p>",
      "unique_key": "DT1166402",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166402,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Botulinum toxin</strong> inhibits <strong>presynaptic release of acetylcholine (ACh)</strong> at all <strong>cholinergic synapses</strong> by cleaving SNARE proteins like <strong>SNAP-25</strong>, which are essential for ACh vesicle fusion and neurotransmitter release.</p>\n<p>As a result, botulinum toxin impairs:</p>\n<ul>\n<li><strong>Somatic neuromuscular transmission</strong> &rarr; Flaccid paralysis</li>\n<li><strong>Parasympathetic activity</strong> &rarr; Mydriasis, <strong>cycloplegia</strong>, dry mouth, constipation</li>\n<li><strong>Autonomic ganglia</strong> &rarr; Hypotension, bradycardia (less prominent)</li>\n</ul>\n<p><strong>Botulinum toxin injections to relax wrinkles</strong>- this illustrates its <strong>spasmolytic</strong> effect, not spasm-inducing.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509069745eba2-5c8a-4da7-b8ce-79eca2f55f75.PNG\">\n<h3>Explanation for Other Options:</h3>\n<p><strong>Bronchospasm (Option A): </strong>This would result from <strong>cholinergic overactivity</strong>. Botulinum toxin causes <strong>bronchodilation</strong> due to parasympathetic blockade.</p>\n<p><strong>Skeletal muscle spasms (Option C): </strong>Botulinum toxin causes <strong>flaccid paralysis</strong>, not spasms. (Contrast this with tetanus toxin.)</p>\n<p><strong>Bradycardia (Option D): </strong>While autonomic blockade may cause <strong>some bradycardia</strong>, it is not as characteristic or reliable as <strong>cycloplegia</strong> for diagnosis.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrointestinal smooth muscle cramping</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased heart rate</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased gastric secretion</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Pupillary constriction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old man is suspected of antimuscarinic drug overdose. Probable signs of overdose include which one of the following?</span></p>",
      "unique_key": "DT1166403",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166403,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Tachycardia</strong> is a characteristic of atropine (antimuscarinic drug) overdose.</p>\n<ul>\n<li>Bradycardia is sometimes observed after small doses.</li>\n<li>Atropine is the <strong>DOC for bradycardia.</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509068315eb9e-1d21-4d77-b2d4-5b7acd396c9c.PNG\">",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4, 5</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 5, 6</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4, 7</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the effect of belladonna alkaloids ?<br>1. Dehydration<br>2. Hallucinations<br>3. Hypertension<br>4. Hyperthermia<br>5. Intraventricular heart block<br>6. Bradycardia<br>7. Bronchoconstriction</span></p>",
      "unique_key": "DT1166406",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166406,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Systemic Side Effects of Antimuscarinic (Belladonna Alkaloids) Drugs:</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509068f17a32d-d959-49e5-b307-d0a06e13da03.PNG\">",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased blood pressure caused by hexamethonium</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased blood pressure caused by nicotine</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Tachycardia caused by exercise</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweating caused by exercise</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one of the following can be blocked by atropine?</span></p>",
      "unique_key": "DT1166407",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166407,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Atropine</strong> is a <strong>muscarinic receptor antagonist</strong>, meaning it <strong>b</strong>locks the actions of acetylcholine (ACh) at muscarinic receptors. It does not affect nicotinic receptors (e.g., at autonomic ganglia or neuromuscular junctions) or <strong>direct sympathetic adrenergic effects</strong>.</p>\n<p>Sweating caused by exercise is sympathetically mediated but <strong>cholinergic in mechanism</strong>.</p>\n<ul>\n<li>Eccrine sweat glands (involved in thermoregulation) are innervated by sympathetic cholinergic fibres.</li>\n<li>These fibres release <strong>ACh</strong>, which acts on <strong>muscarinic M3 receptors</strong> of sweat glands.</li>\n<li><strong>Atropine </strong>blocks these muscarinic receptors, thereby <strong>inhibiting sweating</strong>.</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Decreased blood pressure caused by hexamethonium (Option A): </strong>Hexamethonium is a ganglion blocker (nicotinic receptor antagonist at autonomic ganglia). Atropine acts postganglionically at muscarinic receptors, so it does not reverse ganglionic blockade effects like hypotension.</p>\n<p><strong>Increased blood pressure caused by nicotine (Option B): </strong>Nicotine stimulates nicotinic receptors at autonomic ganglia, leading to sympathetic discharge (&uarr; NE &rarr; vasoconstriction). Atropine does not block nicotinic receptors, hence no effect on this nicotine-induced hypertension.</p>\n<p><strong>Tachycardia caused by exercise (Option C): </strong>Exercise increases sympathetic adrenergic outflow &rarr; &beta;1 activation &rarr; &uarr; heart rate. Atropine only blocks parasympathetic vagal tone, not &beta;-adrenergic effects &rarr; no effect on sympathetic tachycardia.</p>\n<p><strong>Sweating &amp; Autonomic Control</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906cd124fe5-3156-473a-bab4-a9503430fa96.PNG\">",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetylcholine</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexamethonium</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicotine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drug X caused a 50 mm Hg rise in mean blood pressure in the control animal, no blood pressure change in the ganglion-blocked animal, and a 75 mm Hg mean blood pressure rise in the atropine-pretreated animal. Drug X is probably a drug similar to</span></p>",
      "unique_key": "DT1166409",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166409,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Drug X causes an increase in blood pressure that is blocked by a ganglion blocker but not by a muscarinic blocker. The pressor response is increased by pretreatment with atropine, a muscarinic blocker, suggesting that compensatory vagal discharge might have blunted the full response. This description fits a ganglion stimulant like nicotine but not epinephrine, since epinephrine's pressor effects are produced at &alpha; receptors, not in the ganglia.</p>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Scopolamine</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Neostigmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 43-year-old man is presented with confusion and strange behavior. His friend reports that he was eating some wild berries that they had picked during their camping trip. His temperature is 38.7&deg;C (101.7&deg;F). Physical examination shows warm, dry skin and dry mucous membranes. His pupils are dilated and minimally reactive to light. His bowel sounds are decreased. which of the following drugs could lead to complete resolution of symptoms?</span></p>",
      "unique_key": "DT1166410",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166410,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient presents with <strong>anticholinergic toxidrome</strong> following ingestion of wild berries, likely from <strong>Atropa belladonna (deadly nightshade),</strong> which contains <strong>atropine-like alkaloids.</strong></p>\n<ul>\n<li><strong>Physostigmine</strong> is a reversible acetylcholinesterase inhibitor that crosses the blood-brain barrier (BBB).</li>\n<li>It increases<strong> acetylcholine levels both centrally and peripherally,</strong> thereby reversing CNS and peripheral symptoms of atropine toxicity.</li>\n<li>It is the drug of choice in severe<strong> anticholinergic toxicity</strong>, particularly with central manifestations like delirium.</li>\n<li>Don't confuse with <strong>Pyridostigmine</strong> as it <strong>does not cross the BBB </strong>and cannot treat CNS symptoms such as delirium from atropine overdose.</li>\n<li>Pyridostigmine is used for myasthenia gravis and prophylaxis against organophosphates.</li>\n</ul>\n<p>Key <strong>clinical features</strong> of anticholinergic syndrome:</p>\n<ul>\n<li>Hyperthermia (due to decreased sweating)</li>\n<li>Dry skin and mucous membranes</li>\n<li>Mydriasis (dilated pupils minimally reactive to light)</li>\n<li>Decreased bowel sounds</li>\n<li>Confusion, agitation, delirium</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Scopolamine (Option A):</strong> A muscarinic antagonist like atropine, which would worsen anticholinergic symptoms rather than treat them.</p>\n<p><strong>Atropine (Option B):</strong> Also a muscarinic antagonist; it is the cause of anticholinergic toxicity in this context. Not therapeutic here.</p>\n<p><strong>Neostigmine (Option D):</strong> A quaternary acetylcholinesterase inhibitor that does not cross the BBB &rarr; ineffective for central symptoms such as confusion or delirium. Used for the reversal of non-depolarising neuromuscular blockers and urinary retention.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Cycloplegia</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Dry skin in a warm environment</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Miosis</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Postural hypotension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old man has been admitted to the emergency department showing signs of autonomic drug toxicity. Which of the following signs would distinguish between an overdose of a ganglion blocker versus a muscarinic blocker?</span></p>",
      "unique_key": "DT1166411",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166411,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Postural hypotension</strong> is a result of loss of sympathetic vasoconstrictor tone, which helps maintain blood pressure upon standing.</p>\n<ul>\n<li>This effect is characteristic of<strong> ganglion blockers,</strong> since they block sympathetic ganglia.</li>\n<li>Muscarinic blockers do not block sympathetic ganglia, so they do not typically cause postural hypotension.</li>\n</ul>\n<p>To distinguish between an overdose of a <strong>ganglion blocker</strong> and a <strong>muscarinic receptor antagonist</strong>, we need to consider which part of the autonomic nervous system is being affected:</p>\n<ul>\n<li><strong>Ganglion blockers</strong> (e.g., hexamethonium, mecamylamine) block nicotinic receptors at autonomic ganglia, inhibiting both sympathetic and parasympathetic transmission.</li>\n<li><strong>Muscarinic blockers</strong> (e.g., atropine, scopolamine) selectively inhibit parasympathetic postganglionic muscarinic receptors, sparing most sympathetic functions (except those mediated via ACh, like sweating).</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Cycloplegia (Option A):</strong> Both ganglion blockers and muscarinic antagonists can cause cycloplegia (loss of accommodation), since this is controlled by parasympathetic innervation to the ciliary muscle.</p>\n<p><strong>Dry skin in a warm environment (Option B):</strong> Seen with muscarinic blockers, due to inhibition of sympathetic cholinergic fibres to eccrine sweat glands. Ganglion blockers can also reduce sweating by blocking all autonomic output, so this sign is not distinguishing.</p>\n<p><strong>Miosis (Option C):</strong> Neither drug class typically causes miosis. Both can cause mydriasis by inhibiting parasympathetic tone to the pupillary sphincter muscle.</p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Benztropine</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Bethanechol</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Edrophonium</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Neostigmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one of the following drugs causes vasodilation that can be blocked by atropine?</span></p>",
      "unique_key": "DT1166412",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166412,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Bethanechol</strong> is a <strong>direct-acting muscarinic agonist.</strong> It stimulates muscarinic receptors on various smooth muscles, including endothelial M3 receptors in blood vessels. This leads to:</p>\n<ol>\n<li><strong>&uarr; Nitric oxide </strong>(NO) release from endothelial cells</li>\n<li><strong>&rarr; Vasodilation</strong></li>\n<li><strong>&rarr; &darr; Blood pressure</strong></li>\n</ol>\n<p>This effect can be blocked<strong> by atropine,</strong> a muscarinic antagonist, which prevents acetylcholine or muscarinic agonists from binding to M3 receptors.</p>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Benztropine (Option A): </strong>A central antimuscarinic used in Parkinson&rsquo;s disease. It does not cause vasodilation; rather, it can cause tachycardia and dry skin due to muscarinic blockade.</p>\n<p><strong>Edrophonium (Option C):</strong> A short-acting acetylcholinesterase inhibitor (AChEI) used to diagnose myasthenia gravis. It increases endogenous ACh, but since M3 endothelial receptors are not innervated, no vasodilation occurs. Also, its effect is primarily at the neuromuscular junction.</p>\n<p><strong>Neostigmine (Option D):</strong> Another AChEI, mainly acting peripherally. Like edrophonium, it increases ACh but does not cause vasodilation because endothelial M3 receptors lack direct cholinergic innervation.</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Bethanechol</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycopyrrolate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old woman comes to the physician because of increased sweating for the past 6 months. She experiences severe sweating that is triggered by stressful situations and speaking in public. She is failing one of her university classes because she avoids public speaking. She has not had any fevers, chills, weight loss, or night sweats. Her temperature is 36.6&deg;C (98&deg;F). Physical examination shows moist skin in the axillae and on the palms, soles, and face. Which of the following drugs is most likely to be effective for this patient's condition?</span></p>",
      "unique_key": "DT1166533",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166533,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Glycopyrrolate</strong> is a peripherally acting muscarinic antagonist.</p>\n<ul>\n<li>It blocks muscarinic receptors on sweat glands, thereby reducing excessive sweating.</li>\n<li>It does not cross the blood-brain barrier, so it avoids central nervous system (CNS) side effects.</li>\n<li><strong>Sweat glands</strong> (especially eccrine glands) are unique in that they are innervated by sympathetic nerves that release acetylcholine, acting on muscarinic receptors.</li>\n</ul>\n<p>This patient presents with <strong>primary focal hyperhidrosis</strong>, particularly exacerbated by emotional stimuli (e.g., public speaking), and<strong> localised to the palms, soles, axillae, and face.</strong> This type of sweating is due to overactive sympathetic cholinergic stimulation of eccrine sweat glands.</p>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Pilocarpine (Option A): </strong>A muscarinic agonist &ndash; it stimulates sweat glands, salivary glands, and other exocrine glands. This would worsen hyperhidrosis.</p>\n<p><strong>Bethanechol (Option B): </strong>Another muscarinic agonist, mainly used for urinary retention and GI hypomotility. Like pilocarpine, it would increase sweating.</p>\n<p><strong>Physostigmine (Option C):</strong> A reversible acetylcholinesterase inhibitor. Increases ACh levels &rarr; stimulates muscarinic receptors &rarr; increases sweating. Also crosses the BBB, which may cause CNS side effects (e.g., seizures).</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">A: Hemicholinium, B: Vesamicol</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">A: Vesamicol, B: Hemicholinium</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">A: Botulinum, B: Vesamicol</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">A: Vesamicol, B: Botulinum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drugs acting on A and B<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024031935b44051-c293-44d8-befc-cd12e67f8f71.jpg\"></span></p>",
      "unique_key": "DT1166537",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166537,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The drugs acting on sites<strong> A and B</strong> are</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403198c688212-4fa2-4164-b7a6-8e5f25e7b691.jpg\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509064c4f8199-6c76-44e5-82b5-591caf7d5408.PNG\">",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Benztropine</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Amitriptyline</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclizine</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorpromazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old woman with schizophrenia managed for years with a drug, complains of a dry mouth, constipation, blurred vision, and feeling tired. Which of the following drugs was given, causing the given side effects?</span></p>",
      "unique_key": "DT1166541",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166541,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>All of the given drugs <strong>have anticholinergic effects</strong>, but out of these, only <strong>Chlorpromazine is an antipsychotic drug.</strong></p>\n<p><strong>Chlorpromazine</strong> is a <strong>typical antipsychotic </strong>(low potency, first-generation) with strong antimuscarinic (anticholinergic) effects. It also has sedative properties due to histamine (H1) receptor blockade.</p>\n<p><strong>Anticholinergic side effects</strong> include:</p>\n<ul>\n<li>Dry mouth</li>\n<li>Constipation</li>\n<li>Blurred vision</li>\n<li>Urinary retention</li>\n<li>Sedation/fatigue</li>\n</ul>\n<p>Explanation for Other Options:</p>\n<p><strong>Benztropine (Option A): </strong>Anticholinergic used to treat extrapyramidal symptoms (EPS) in Parkinsonism or drug-induced dystonia. While it causes similar anticholinergic side effects, it is not used to treat schizophrenia, making it unlikely in this context.</p>\n<p><strong>Amitriptyline (Option B): </strong>A tricyclic antidepressant (TCA) with anticholinergic and antihistaminic effects. It can cause these symptoms, but it is used for depression, neuropathic pain, or migraine prophylaxis, not schizophrenia.</p>\n<p><strong>Cyclizine (Option C): </strong>An antihistamine (H1 blocker) used for motion sickness and nausea.<br /> It has mild anticholinergic properties, but again, not indicated for schizophrenia.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Drugs with Moderate to Strong Anticholinergic Effects:</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509068d1cc78d-582f-4bb8-a853-1c9da5366c04.PNG\">",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocks acetylcholine degradation</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates nicotinic cholinergic receptors</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates acetylcholine release</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates muscarinic cholinergic receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old woman complains of fatigue that increases throughout the day. At the end of her workday, she says her eyes feel \"heavy\" and \"droopy,\" although she does not feel particularly tired. A drug is prescribed to treat her myasthenia gravis. How does the drug work?</span></p>",
      "unique_key": "DT1166548",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Myasthenia gravis</strong> is an autoimmune disorder in which <strong>autoantibodies attack nicotinic acetylcholine receptors (nAChRs) </strong>at the neuromuscular junction, leading to weakness, especially after exertion.</p>\n<ul>\n<li>The standard treatment includes <strong>acetylcholinesterase inhibitors such as pyridostigmine,</strong> which work by blocking acetylcholine degradation.</li>\n<li>This increases the amount of ACh available at the neuromuscular junction, allowing stimulation of the remaining unblocked receptors and<strong> improving muscle strength</strong>.</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Stimulates nicotinic cholinergic receptors (Option B):</strong> Drugs like nicotine directly stimulate nicotinic receptors, but pyridostigmine does not act directly on receptors; it enhances endogenous ACh action by preventing its breakdown.</p>\n<p><strong>Stimulates acetylcholine release (Option C): </strong>While increased ACh release might be beneficial, pyridostigmine does not affect ACh release. Instead, it increases synaptic ACh levels by inhibiting acetylcholinesterase.</p>\n<p><strong>Stimulates muscarinic cholinergic receptors (Option D):</strong> Drugs such as bethanechol and pilocarpine are direct muscarinic agonists, affecting organs like the bladder or eye. Pyridostigmine affects both nicotinic and muscarinic systems indirectly by increasing ACh but is not a direct muscarinic agonist.</p>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbachol</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Galantamine</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Rivastigmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman presents to the ophthalmologist for a routine eye examination. She is given intraocular pilocarpine, two drops in each eye, to dilate the eyes for the examination. Unfortunately, the eyedrops were inadvertently administered 10 drops of pilocarpine in each eye. Which of the following agents should be immediately given to the patient?</span></p>",
      "unique_key": "DT1166551",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166551,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Pilocarpine</strong> is a direct muscarinic cholinergic agonist used in ophthalmology to induce miosis (pupil constriction) and reduce intraocular pressure. An overdose may cause excessive parasympathomimetic effects, particularly:</p>\n<ul>\n<li>Profound miosis</li>\n<li>Ciliary muscle spasm &rarr; blurred vision</li>\n<li>Headache and eye discomfort</li>\n</ul>\n<p><strong>Atropine</strong> is the treatment of choice in this setting as it acts as a competitive muscarinic receptor antagonist, reversing excessive cholinergic effects by:</p>\n<ul>\n<li>Relaxing the sphincter pupillae muscle &rarr; Mydriasis</li>\n<li>Relieving ciliary muscle spasm</li>\n<li>Restoring visual comfort</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Carbachol (Option B): </strong>Another direct cholinergic agonist-it would worsen the symptoms by further stimulating muscarinic receptors, aggravating miosis and visual discomfort.</p>\n<p><strong>Galantamine (Option C): </strong>An acetylcholinesterase inhibitor used for Alzheimer's disease. It increases central ACh levels and has no role in reversing pilocarpine effects-may even worsen symptoms if systemically absorbed.</p>\n<p><strong>Rivastigmine (Option D): </strong>Similar to galantamine, this drug also inhibits acetylcholinesterase and cannot reverse muscarinic overstimulation in the eye.</p>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blocker</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholinesterase inhibitor</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium channel blocker</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium channel blocker</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman with end-stage multiple sclerosis who is on prednisone and neostigmine. After examination, the patient has begun on dalfampridine. What is the most likely mechanism of action for this medication?</span></p>",
      "unique_key": "DT1166556",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166556,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Dalfampridine</strong> (also known as fampridine) is a potassium channel blocker used symptomatically in <strong>multiple sclerosis.</strong> Its primary benefit is improving walking ability, particularly gait speed, by <strong>enhancing conduction in demyelinated neurons.</strong></p>\n<ul>\n<li>In MS, demyelination slows or blocks action potential conduction.</li>\n<li>Blocking potassium channels helps prolong the action potential and enhance neurotransmission in demyelinated axons.</li>\n<li>It is not a disease-modifying therapy but provides symptomatic relief (especially for ambulation).</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Calcium channel blocker (Option A):</strong> Used in hypertension and angina, not indicated in MS. Example: Nifedipine.</p>\n<p><strong>Cholinesterase inhibitor (Option B): </strong>These agents increase acetylcholine levels but do not improve MS gait symptoms. Example: Pyridostigmine, used in myasthenia gravis. Neostigmine is already being used in this patient for another indication.</p>\n<p><strong>Sodium channel blocker (Option D): </strong>Some antiepileptics and local anaesthetics block sodium channels. However, dalfampridine does not act via this mechanism.</p>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Echothiophate</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Neostigmine</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridostigmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old man has increased intraocular pressure bilaterally. You start him on a drug used to treat his open-angle glaucoma, which also happens to cross the blood-brain barrier better than other drugs in its class. Which of the following drugs is this?</span></p>",
      "unique_key": "DT1166558",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Physostigmine</strong> is a <strong>reversible acetylcholinesterase inhibitor</strong> that readily crosses the blood-brain barrier due to its tertiary amine structure. It enhances cholinergic activity in the eye by promoting contraction of the ciliary muscle, thereby <strong>increasing aqueous humour drainage</strong> through the trabecular meshwork and reducing intraocular pressure.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Echothiophate (Option A): </strong>An irreversible acetylcholinesterase inhibitor used for glaucoma, but does not cross the blood-brain barrier due to its quaternary ammonium structure.</p>\n<p><strong>Neostigmine (Option B): </strong>Commonly used for postoperative urinary retention and reversal of neuromuscular blockade. It is a quaternary compound and cannot enter the CNS.</p>\n<p><strong>Pyridostigmine (Option D): </strong>Primarily prescribed for myasthenia gravis. Like neostigmine, it is a quaternary amine and therefore does not penetrate the blood-brain barrier.</p>",
      "correct_choice_id": 253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old man presented with focal dystonia. The drugs acting at which site can be used in treatment?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024031935b44051-c293-44d8-befc-cd12e67f8f71.jpg\"></span></p>",
      "unique_key": "DT1166560",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509065794d9e1-f434-4bc3-ab89-cc19c31f6cb1.jpg\">\n<p>As in the illustrated diagram, <strong>C) Botulinum toxin</strong> helps to relieve focal dystonia.</p>\n<p><strong>Other </strong><strong>uses of botulinum</strong> are</p>\n<ul>\n<li>Blepharospasm</li>\n<li>Hemifacial spasm</li>\n<li>Laryngeal dysphonia</li>\n<li>Cervical dystonia</li>\n<li>Jaw-closing oromandibular dystonia</li>\n</ul>",
      "correct_choice_id": 263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Methacholine</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Edrophonium</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Cevimeline</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Bethanechol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is used for the Diagnosis of bronchial hypersensitivity?</span></p>",
      "unique_key": "DT1166561",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Methacholine</strong> is a muscarinic receptor agonist that is used only for diagnostic purposes, specifically in the <strong>methacholine challenge test</strong>, which assesses <strong>bronchial hyperreactivity</strong>-a hallmark of asthma.</p>\n<ul>\n<li>It acts on muscarinic receptors in the <strong>airway smooth muscle</strong>, causing <strong>bronchoconstriction</strong>.</li>\n<li>Since it is a quaternary amine, it <strong>does not cross the blood-brain barrier</strong>.</li>\n<li>The test involves inhalation of increasing concentrations of methacholine, with spirometry used to detect a drop in <strong>FEV<sub>1</sub>. </strong></li>\n<li>A significant decrease confirms bronchial hyperresponsiveness.</li>\n<li>This drug is not used therapeutically due to its potential to cause severe bronchoconstriction.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Edrophonium (Option B):</strong> A very short-acting acetylcholinesterase inhibitor used primarily in the diagnosis of <strong>myasthenia gravis</strong> (edrophonium test). It does not act on muscarinic receptors in the lungs and is not involved in bronchial reactivity testing.</p>\n<p><strong>Cevimeline (Option C):</strong> A muscarinic agonist used in <strong>Sj&ouml;gren syndrome</strong> to stimulate salivary and sweat glands. It has no application in respiratory diagnostics.</p>\n<p><strong>Bethanechol (Option D):</strong> A muscarinic agonist that increases bladder and gastrointestinal smooth muscle tone, used in <strong>postoperative ileus and urinary retention</strong>. It does not affect bronchial tone in a diagnostic setting.</p>",
      "correct_choice_id": 271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-a, 4-d</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-a, 3-b, 4-d</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-d, 4-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following drugs with their indication<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090613080854-039e-4be9-bf57-4be90b426fbe.PNG\"></span></p>",
      "unique_key": "DT1166562",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090673e4487a-0292-4561-be00-02e122221588.PNG\">",
      "correct_choice_id": 281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-3, C-2</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-3, C-1</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-1, C-3</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-1, C-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the type of incontinence with pharmacotherapy of the same<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024072342044ca2-fc20-4ed4-8176-cbb2e4335d65.jpg\"></span></p>",
      "unique_key": "DT1166571",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509061af13d72-0134-4d60-a881-034383e878b1.PNG\">",
      "correct_choice_id": 292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">Morning sickness</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">Motion sickness</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">Smoking cessation</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">Analgesia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You're being asked to use of drug given below in your pharmacology viva.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202312121caa743f-5833-49b2-9642-1e542a5190d1.jpg\"></span></p>",
      "unique_key": "DT1166576",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166576,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Scopolamine</strong> is a <strong>muscarinic receptor antagonist</strong> (anticholinergic) that is particularly effective in the <strong>prevention and treatment of motion sickness</strong>.</p>\n<ul>\n<li>It acts on the vestibular system by inhibiting cholinergic transmission from the vestibular nuclei to the vomiting centre in the brainstem.</li>\n<li>It is typically administered via a <strong>transdermal patch</strong> for long-lasting prophylaxis.</li>\n<li>Acetazolamide is used for mountain sickness.</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Morning sickness (Option A): </strong>This is best treated with <strong>doxylamine + pyridoxine</strong>, <strong>not scopolamine</strong>.</p>\n<p><strong>Smoking cessation (Option C): </strong>This is treated with agents like <strong>nicotine patches</strong> or <strong>varenicline</strong>.</p>\n<p><strong>Analgesia (Option D): </strong>This is not a primary use of scopolamine.</p>",
      "correct_choice_id": 302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">Tiotropium bromide</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Ipratropium bromide</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Salbutamol</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">Salmeterol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67-year-old man with COPD needs longer longer-acting bronchodilator, which is the ideal candidate for the same?</span></p>",
      "unique_key": "DT1166579",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166579,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Tiotropium bromide</strong> is a long-acting muscarinic antagonist (LAMA) that provides sustained bronchodilation by blocking M3 receptors, thereby preventing<strong> bronchoconstriction.</strong> It is ideal for long-term maintenance therapy in COPD, particularly for grades II and above&nbsp;</p>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Ipratropium bromide (Option B):</strong> A short-acting muscarinic antagonist (SAMA) with a shorter duration, used in mild COPD or acute settings.</p>\n<p><strong>Salbutamol (Option C): </strong>A short-acting beta2 agonist (SABA), primarily used for asthma or quick relief in COPD.</p>\n<p><strong>Salmeterol (Option D):</strong> A long-acting beta2 agonist (LABA) useful in COPD, but muscarinic antagonists like tiotropium are generally preferred for long-acting bronchodilation in COPD.</p>",
      "correct_choice_id": 311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">Stable bradycardia</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">Before intubation</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">Scorpion stings</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">Uveitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an indication of the drug given below?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231212db7e227f-edd0-4274-8677-9834b2471e75.jpg\"></span></p>",
      "unique_key": "DT1166581",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Atropine</strong> is a muscarinic receptor antagonist used primarily in <strong>unstable (symptomatic) bradycardia</strong>, not in stable cases.</p>\n<ul>\n<li>In symptomatic bradycardia, it blocks vagal influence on the SA node, thereby increasing heart rate.</li>\n<li>It is <strong>not indicated</strong> in stable bradycardia, where no significant symptoms or haemodynamic compromise are present.</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Before intubation (Option B):</strong> Atropine is used as premedication before intubation, especially in children, to reduce salivary and airway secretions.</p>\n<p><strong>Scorpion stings (Option C):</strong> Atropine is used to counteract the parasympathetic overactivity (e.g., excessive salivation, bronchorrhoea) caused by venom-induced acetylcholine release.</p>\n<p><strong>Uveitis (Option D):</strong> Atropine is used in ophthalmology to dilate the pupil and prevent synechiae formation in anterior uveitis.</p>",
      "correct_choice_id": 321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34,
      "choices": [
        {
          "id": 331,
          "text": "<p><span style=\"font-size:12.0pt;\">Trospium</span></p>"
        },
        {
          "id": 332,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxybutynin</span></p>"
        },
        {
          "id": 333,
          "text": "<p><span style=\"font-size:12.0pt;\">Tolterodine</span></p>"
        },
        {
          "id": 334,
          "text": "<p><span style=\"font-size:12.0pt;\">Solifenacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old male with Alzheimer's disease has complained of multiple episodes of a strong, sudden sense of urinary urgency with incontinence. Which of the following is the ideal agent for him for this condition?</span></p>",
      "unique_key": "DT1166582",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166582,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In elderly patients with Alzheimer's disease, <strong>cognitive function </strong>is highly sensitive to central anticholinergic effects, which can worsen dementia symptoms.</p>\n<ul>\n<li><strong>Trospium</strong> is a <strong>quaternary ammonium compound</strong>, meaning it is hydrophilic and poorly crosses the blood-brain barrier (BBB), thus sparing the central nervous system from unwanted anticholinergic side effects.</li>\n<li>It is the preferred agent for treating <strong>urge incontinence</strong> in patients with Alzheimer's, as it reduces bladder overactivity <strong>without compromising cognition</strong>.</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Oxybutynin (Option B):</strong> Though effective for urge incontinence, it is a tertiary amine that crosses the BBB, often associated with central side effects like confusion and sedation, especially in the elderly.</p>\n<p><strong>Tolterodine (Option C):</strong> Also a tertiary amine, it may cause CNS effects due to central cholinergic blockade, thus less ideal in Alzheimer's.</p>\n<p><strong>Solifenacin (Option D):</strong> Another tertiary amine with CNS penetration; although bladder-selective, it still poses a risk for cognitive decline in dementia patients.</p>",
      "correct_choice_id": 331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35,
      "choices": [
        {
          "id": 341,
          "text": "<p><span style=\"font-size:12.0pt;\">Bethanechol</span></p>"
        },
        {
          "id": 342,
          "text": "<p><span style=\"font-size:12.0pt;\">Distigmine</span></p>"
        },
        {
          "id": 343,
          "text": "<p><span style=\"font-size:12.0pt;\">Cevimeline</span></p>"
        },
        {
          "id": 344,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbachol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman complains of severe bloating after undergoing abdominal surgery. She also finds it difficult to urinate. Mild cholinomimetic stimulation without vasodilation is preferred for treatment. Which agent should be preferred?</span></p>",
      "unique_key": "DT1166583",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166583,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In post-operative ileus and urinary retention, <strong>cholinomimetic agents</strong> are used to stimulate smooth muscle activity in the bladder and gastrointestinal tract.</p>\n<ul>\n<li>While both bethanechol and distigmine can help, <strong>distigmine</strong> is preferred here because it provides mild cholinergic stimulation <strong>without causing vasodilation</strong>.</li>\n<li>This is crucial in patients who are haemodynamically vulnerable post-surgery.</li>\n<li><strong>Distigmine</strong>, as an <strong>acetylcholinesterase inhibitor</strong>, increases endogenous acetylcholine levels without directly stimulating muscarinic receptors on vascular endothelium, thereby avoiding vasodilation, unlike bethanechol, which is a direct muscarinic agonist.</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Bethanechol (Option A):</strong> A direct muscarinic agonist that stimulates GI and bladder smooth muscle but <strong>also causes vasodilation via endothelial M3 receptor activation</strong>, which is <strong>not desirable</strong> in this scenario.</p>\n<p><strong>Cevimeline (Option C):</strong> Primarily used to treat <strong>xerostomia</strong> in Sj&ouml;gren's syndrome; it acts mostly on <strong>M3 receptors in exocrine glands</strong> and has <strong>no clinical role in postoperative ileus or urinary retention</strong>.</p>\n<p><strong>Carbachol (Option D):</strong> Though a strong cholinergic agonist, it affects <strong>both muscarinic and nicotinic receptors</strong> and may cause <strong>excessive cholinergic side effects</strong>, making it unsuitable for controlled stimulation in postoperative settings.</p>",
      "correct_choice_id": 342,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 36,
      "choices": [
        {
          "id": 351,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, 3, 5/ B-2, 4, 6/ C-7</span></p>"
        },
        {
          "id": 352,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, 4, 5 / B-2, 3, 6 / C-7</span></p>"
        },
        {
          "id": 353,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, 3, 5 / B-2, 4 / C-6, 7</span></p>"
        },
        {
          "id": 354,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, 3/ B-2, 4, 5/ C-6, 7</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the action of receptor with post-receptor mechanism<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090658814e25-8960-4c15-b0a0-a122917361e8.PNG\"></span></p>",
      "unique_key": "DT1166585",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509066caae2d5-e64d-4513-8879-de4307d8e869.PNG\">\n<p><strong>Cholinergic Receptors - G-Proteins, Effects, and Locations</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250906f5de0392-113e-484c-8145-34a6ba525543.PNG\">",
      "correct_choice_id": 353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37,
      "choices": [
        {
          "id": 361,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemicholinium</span></p>"
        },
        {
          "id": 362,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetrodotoxin</span></p>"
        },
        {
          "id": 363,
          "text": "<p><span style=\"font-size:12.0pt;\">Vesamicol</span></p>"
        },
        {
          "id": 364,
          "text": "<p><span style=\"font-size:12.0pt;\">Conotoxin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A researcher studying a drug, \"Reserpine\", acts on an adrenergic neuron. Similar action on cholinergic neurons is seen by?</span></p>",
      "unique_key": "DT1166589",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166589,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231212ac6a4894-3698-4e2a-a743-045b1117057a.jpg\">\n<p>Both <strong>Vesamicol and Reserpine</strong> act as transmitter storage and deplete it in vesicles of cholinergic and adrenergic terminals, respectively.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509064d7c1dbf-4a5f-4673-923c-b7c44fd017ee.PNG\">",
      "correct_choice_id": 363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}